Jianwei Liang
26 Papers
5 Citations
Jianwei Liang is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 19 publications.
Chat about Author
Papers
Effect of acupuncture on postoperative ileus after laparoscopic elective colorectal surgery: A prospective, randomised, controlled trial
Jing-Wen Yang,Jia-Kai Shao,Yu Wang,Qiankun Liu,Jianwei Liang,Shiyan Yan,Sicheng Zhou,Na-Na Yang,Li-Qiong Wang,Guang-Xia Shi,Wei-dong Pei,Cun-Zhi Liu +11 more
TL;DR: In this paper , the effect of electroacupuncture at different single acupoint combined with standard care on postoperative ileus was investigated, and the results showed that the EA at ST36 and ST25 groups significantly increased the time to first flatus and defecation.
37
Prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: a propensity score matching study
TL;DR: In this paper , the authors investigated whether the addition of LPND to total mesorectal excision (TME) confers survival benefits in rectal cancer patients with clinical lateral pelvic node metastasis (LPNM).
Short‐ and long‐term outcomes of laparoscopic versus open selective lateral pelvic lymph node dissection for locally advanced middle‐low rectal cancer: Results of a multicentre lateral node study in China
TL;DR: Laroscopic LPND is technically safe and feasible with favourable short-term results and similar oncological outcomes as open surgery in selected patients, and LPNM was an independent predictor of survival.
8
Effective dissecting range and prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: Results of a large multicenter lateral node collaborative group in China
TL;DR: LPND may be effective in controlling local recurrence in patients with LPN metastasis but not systemic metastases, and their prognoses may be comparable to those at the N2b stage.
7
Neoadjuvant chemotherapy with modified FOLFOXIRI for locally advanced rectal cancer to transform effectively EMVI and MRF from positive to negative: results of a long-term single center phase 2 clinical trial
Wen Zhang,Haitao Zhou,Jun Jiang,Yuelu Zhu,Shuang-mei Zou,Liming Jiang,Yu Tang,Jianwei Liang,Yongjun Sun,Zhichao Jiang,Wang Qu,Ying Li,Aiping Zhou +12 more
TL;DR: In this paper , the authors evaluated the efficacy and safety of triplet chemotherapy with mFOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin, and irinotecan) in LARC.